株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

体外診断 (IVD) の世界市場 〜2021年:製品 (器具、試薬、ソフトウェア) ・技術 (免疫測定、臨床化学、分子診断、血液学) ・用途別

In Vitro Diagnostics/IVD Market: Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to 2021

発行 MarketsandMarkets 商品コード 239720
出版日 ページ情報 英文 309 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。
Back to Top
体外診断 (IVD) の世界市場 〜2021年:製品 (器具、試薬、ソフトウェア) ・技術 (免疫測定、臨床化学、分子診断、血液学) ・用途別 In Vitro Diagnostics/IVD Market: Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to 2021
出版日: 2016年12月02日 ページ情報: 英文 309 Pages
概要

世界のIVD市場は、2021年には787億4,000万米ドルの規模に達する見込みとなっており、2016年から2021年にかけてのCAGR (複合年間成長率) は5.5%になるものと予測されています。

当レポートでは、体外診断 (IVD) 市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、製品別 (器具、試薬、ソフトウェア、サービス) ・技術別 (免疫測定、臨床化学、分子診断、血液学) ・用途別 (糖尿病、癌、心臓、自己免疫疾患) ・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめています。

第1章 イントロダクション

  • 調査の目的
  • 市場の定義
  • 市場の範囲
    • 網羅した市場
    • 調査の対象とした年
  • 通貨
  • 制約
  • ステークホルダー

第2章 調査手法

  • 調査データ
    • 一次データ
    • 二次データ
  • 市場規模推定
  • 市場内訳とデータの三角測量
  • 市場シェア推定
  • 調査の前提条件

第3章 エグゼクティブサマリー

第4章 重要考察

  • IVD市場の成長可能性
  • アジア太平洋IVD市場
  • IVD市場:地域概観
  • 地域ミックス:IVD市場、技術別
  • IVD市場:新興VS先進市場

第5章 体外診断 (IVD) の世界市場:概要

  • イントロダクション
  • 市場動態
    • 市場発展促進要因
      • 慢性生活習慣病の発生率の上昇
      • ポイントオブケア (POC) 検査の導入拡大
      • オーダーメイド医療の認知度の拡大
      • 個人向け検診センターの増加
    • 市場発展阻害要因
      • 不十分な補償
      • 医療費の増加と低予算
    • 市場機会
      • ゲノミクスおよびプロテオミクスの発展に伴う、新たな条件の特異なマーカーおよび検査の導入
      • 投資が増加している新興経済
      • 重要性を増すコンパニオン診断
    • 課題
      • 厳しい規制の枠組み
      • 診断検査利用上の運用障壁

第6章 体外診断 (IVD) の世界市場:産業動向

  • イントロダクション
  • 産業動向
    • 臨床検査技術の自動化
    • 臨床検査向けマイクロ流体工学ベースのPoc/Loc診断装置
    • 試薬のレンタル契約の増加
  • 規制概要
    • 北米
      • 米国
      • カナダ
    • 欧州
    • アジア太平洋
      • 日本
      • 中国
      • インド

第7章 体外診断 (IVD) の世界市場:製品・サービス別

  • イントロダクション
  • 試薬とキット
  • 器具
  • データ管理ソフトウェア
  • 諸サービス

第8章 体外診断 (IVD) の世界市場:技術別

  • イントロダクション
  • 臨床化学
  • 免疫化学/免疫測定法
  • 臨床化学
  • 分子診断学 (MDX)
  • 臨床微生物学
  • 血液学
  • 凝析・止血
  • その他のIVD技術

第9章 体外診断 (IVD) の世界市場:用途別

  • イントロダクション
  • 糖尿病
  • 感染症
  • 腫瘍/癌
  • 心臓
  • 腎臓
  • 自己免疫疾患
  • 薬物検査
  • HIV/AIDS
  • その他の用途

第10章 体外診断 (IVD) の世界市場:エンドユーザー別

  • イントロダクション
  • 研究所
  • 病院
  • 学術機関
  • ポイントオブケア (POC) 検査
  • 患者の自己検査
  • その他

第11章 体外診断 (IVD) の世界市場:地域別分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他の欧州 (ROE)
  • アジア太平洋 (APAC)
    • 日本
    • 中国
    • インド
    • その他アジア太平洋 (ROAPAC)
  • その他地域 (ROW)
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ (RoLA)
    • 中東・アフリカ

第12章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向
  • 新製品発表
  • 合意、パートナーシップ、協業
  • 買収
  • 事業拡張
  • その他の戦略

第13章 企業プロファイル

  • イントロダクション
  • ABBott Laboratories, Inc.
  • Becton, Dickinson and Company
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Johnson & Johnson
  • Roche Diagnostics
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Ortho-Clinical Diagnostics, Inc.
  • Qiagen N.V.
  • Diasorin S.P.A.

第14章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3609

The global IVD market is projected to reach USD 78.74 billion by 2021, at a CAGR of 5.5% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the increasing prevalence of diseases such as diabetes, cardiovascular diseases, and across the globe and shift in focus from centralized laboratories to decentralized point-of-care testing is also support the growth of the IVD market.

In this report, the global IVD market is segmented by products & services, technology, application, end user, and region. Based on technology, the IVD market is mainly segmented into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies. The immunoassays/immunochemistry segment accounted for the largest share of the IVD market in 2015. The growing preference for these technologies in clinical diagnostics over conventional methods and the ability of immunoassay/immunochemistry technologies to offer faster results with high sensitivity and accuracy are contributing to the growth of immunoassays/immunochemistry market during forecast period.

Based on application, the market is segmented into diabetes, infectious diseases, oncology/cancer, cardiology, HIV/AIDS, autoimmune diseases, nephrology, drug testing/pharmacogenomics, and other applications. In 2015, the infectious diseases segment accounted for the largest share of the IVD market. The oncology/cancer segment is expected to register the highest CAGR during the forecast period due to the growing incidence of cancer forms that stimulates the demand for early detection of the disease.

In 2015, North America commanded the largest share of the IVD market, followed by Europe. The U.S. is a prime market for IVD due to the rising acceptance of point-of-care diagnostics and patient self-testing practices in the country. The Asia-Pacific market is expected to witness the highest growth in the coming years primarily due to the growing focus of manufacturers on this region.

Major players in the global IVD market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMerieux (France), Becton, Dickinson and Company (U.S.), Johnson and Johnson (U.S.), Ortho-Clinical Diagnostics, Inc. (U.S.), Qiagen N.V. (Germany), and Diasorin S.P.A. (Italy).

Research Coverage:

  • Detailed insights on all the submarkets, based on technology (immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies), this can help market players to identify high growth segments in the IVD market.
  • The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner.
  • Key insights and market sizing for the different end users of the IVD market namely, hospitals, laboratories, academic institutes, point-of-care testing, patient self-testing, and other end users.
  • Country-wise market size and forecast for all the sub segments. Thus, not only the high growth products & services, technology, application, and end user areas; the market size numbers provided in the report will also enable market players to identify key geographic markets, and thereby strategize global marketing efforts in order to achieve sustainable revenue growth in the coming years.
  • It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for increasing their market shares.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by top players in the IVD market. The report analyzes the market by product type across all regions
  • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the IVD market
  • Market Development: Comprehensive information on lucrative emerging markets, based on products & services, technology, application, end user, and region
  • Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the IVD market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of leading players in the IVD market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. IN VITRO DIAGNOSTICS (IVD): MARKET OVERVIEW
  • 4.2. ASIA-PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET
  • 4.4. GEOGRAPHIC MIX: IN VITRO DIAGNOSTICS MARKET
  • 4.5. IN VITRO DIAGNOSTICS MARKET: DEVELOPING VS. DEVELOPED MARKETS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Rising incidence of chronic lifestyle diseases
      • 5.2.1.2. Increasing adoption of point-of-care testing
      • 5.2.1.3. Growing awareness of personalized medicine
      • 5.2.1.4. Growth in the number of private diagnostic centers
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. Inadequate reimbursement
      • 5.2.2.2. Rising healthcare costs and low budgets
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Introduction of a new range of condition-specific markers and tests with advances in genomics and proteomics
      • 5.2.3.2. Emerging economies with increasing investments
      • 5.2.3.3. Growing significance of companion diagnostics
    • 5.2.4. MARKET CHALLENGES
      • 5.2.4.1. Stringent regulatory framework
      • 5.2.4.2. Operational barriers for the use of diagnostic tests

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. INDUSTRY TRENDS
    • 6.2.1. AUTOMATION OF CLINICAL LABORATORY TECHNIQUES
    • 6.2.2. MICROFLUIDICS-BASED POC AND LOC DIAGNOSTIC DEVICES FOR LABORATORY TESTING
    • 6.2.3. RISE IN REAGENT RENTAL AGREEMENTS
  • 6.3. REGULATORY OVERVIEW
    • 6.3.1. NORTH AMERICA
      • 6.3.1.1. U.S.
      • 6.3.1.2. Canada
    • 6.3.2. EUROPE
    • 6.3.3. ASIA-PACIFIC
      • 6.3.3.1. Japan
      • 6.3.3.2. China
      • 6.3.3.3. India

7. GLOBAL IVD MARKET, BY PRODUCT & SERVICE

  • 7.1. INTRODUCTION
  • 7.2. REAGENTS & KITS
  • 7.3. INSTRUMENTS
  • 7.4. DATA MANAGEMENT SOFTWARE
  • 7.5. SERVICES

8. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. IMMUNOCHEMISTRY/IMMUNOASSAYS
    • 8.2.1. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
      • 8.2.1.1. Chemiluminescence immunoassays (CLIAS)
      • 8.2.1.2. Fluorescence immunoassays (FIAS)
      • 8.2.1.3. Colorimetric immunoassays (CIS)
    • 8.2.2. RADIOIMMUNOASSAY (RIA)
    • 8.2.3. RAPID TESTS
    • 8.2.4. WESTERN BLOT
    • 8.2.5. ENZYME-LINKED IMMUNOSPOT (ELISPOT) ASSAY
  • 8.3. CLINICAL CHEMISTRY
    • 8.3.1. BASIC METABOLIC PANEL
    • 8.3.2. ELECTROLYTE PANEL
    • 8.3.3. LIVER PANEL
    • 8.3.4. LIPID PROFILE
    • 8.3.5. RENAL PROFILE
    • 8.3.6. THYROID FUNCTION PANEL
    • 8.3.7. SPECIALTY CHEMICAL TESTS
  • 8.4. MOLECULAR DIAGNOSTICS (MDX)
    • 8.4.1. POLYMERASE CHAIN REACTION (PCR)
    • 8.4.2. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
    • 8.4.3. MICROARRAY
    • 8.4.4. HYBRIDIZATION
    • 8.4.5. DNA SEQUENCING & NEXT-GENERATION SEQUENCING
    • 8.4.6. OTHER MDX TECHNOLOGIES
  • 8.5. CLINICAL MICROBIOLOGY
  • 8.6. HEMATOLOGY
  • 8.7. COAGULATION AND HEMOSTASIS
  • 8.8. OTHER IVD TECHNOLOGIES

9. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. DIABETES
  • 9.3. INFECTIOUS DISEASES
  • 9.4. ONCOLOGY/CANCER
  • 9.5. CARDIOLOGY
  • 9.6. NEPHROLOGY
  • 9.7. AUTOIMMUNE DISEASES
  • 9.8. DRUG TESTING/PHARMACOGENOMICS
  • 9.9. HIV/AIDS
  • 9.10. OTHER APPLICATIONS

10. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. HOSPITALS
  • 10.3. LABORATORIES
  • 10.4. POINT-OF-CARE TESTING
  • 10.5. PATIENT SELF-TESTING
  • 10.6. ACADEMIC INSTITUTES
  • 10.7. OTHER END USERS

11. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. RUSSIA
    • 11.3.7. REST OF EUROPE (ROE)
  • 11.4. ASIA-PACIFIC (APAC)
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA-PACIFIC (ROAPAC)
  • 11.5. LATIN AMERICA
    • 11.5.1. BRAZIL
    • 11.5.2. MEXICO
    • 11.5.3. REST OF LATIN AMERICA (ROLA)
  • 11.6. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE SITUATION AND TRENDS
  • 12.4. NEW PRODUCT LAUNCHES
  • 12.5. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
  • 12.6. ACQUISITIONS
  • 12.7. EXPANSIONS
  • 12.8. OTHER STRATEGIES

13. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 13.1. INTRODUCTION
  • 13.2. ABBOTT LABORATORIES, INC.
  • 13.3. BECTON, DICKINSON AND COMPANY
  • 13.4. BIOMERIEUX SA
  • 13.5. BIO-RAD LABORATORIES, INC.
  • 13.6. DANAHER CORPORATION
  • 13.7. JOHNSON & JOHNSON
  • 13.8. ROCHE DIAGNOSTICS
  • 13.9. SIEMENS AG
  • 13.10. SYSMEX CORPORATION
  • 13.11. THERMO FISHER SCIENTIFIC, INC.
  • 13.12. ORTHO-CLINICAL DIAGNOSTICS, INC.
  • 13.13. QIAGEN N.V.
  • 13.14. DIASORIN S.P.A.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS
  • 14.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL IVD MARKET SNAPSHOT
  • TABLE 2: NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2015 VS. 2040 (MILLION INDIVIDUALS)
  • TABLE 3: IMPACT ANALYSIS: MARKET DRIVERS
  • TABLE 4: IMPACT ANALYSIS: MARKET RESTRAINTS
  • TABLE 5: IMPACT ANALYSIS: MARKET OPPORTUNITIES
  • TABLE 6: IMPACT ANALYSIS: MARKET CHALLENGES
  • TABLE 7: U.S.: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
  • TABLE 8: U.S.: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 9: CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 10: EUROPE: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
  • TABLE 11: EUROPE: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 12: JAPAN: CLASSIFICATION OF IVD DEVICES
  • TABLE 13: JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 14: CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 15: INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 16: GLOBAL IVD MARKET, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL IVD REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL IVD REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL IVD INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: GLOBAL IVD INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL IVD DATA MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL IVD DATA MANAGEMENT SOFTWARE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 23: GLOBAL IVD SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: GLOBAL IVD SERVICES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL IMMUNOASSAY/IMMUNOCHEMISTRY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 27: GLOBAL IVD MARKET SIZE FOR IMMUNOCHEMISTRY/IMMUNOASSAY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: GLOBAL ELISA MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 30: GLOBAL CHEMILUMINESCENCE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: GLOBAL FLUORESCENCE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: GLOBAL COLORIMETRIC IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: GLOBAL RADIOIMMUNOASSAY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL RAPID TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL WESTERN BLOT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: GLOBAL ELISPOT ASSAY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: GLOBAL IVD MARKET SIZE FOR CLINICAL CHEMISTRY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL BASIC METABOLIC PANEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: GLOBAL ELECTROLYTE PANEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: GLOBAL LIVER PANEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: GLOBAL LIPID PROFILE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: GLOBAL RENAL PROFILE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL THYROID FUNCTION PANEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: GLOBAL SPECIALTY CHEMICAL TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: GLOBAL IVD MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 48: GLOBAL PCR MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: GLOBAL INAAT MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 50: GLOBAL MICROARRAY MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: GLOBAL HYBRIDIZATION MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: GLOBAL DNA SEQUENCING & NGS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: GLOBAL OTHER MDX TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 54: GLOBAL IVD MARKET SIZE FOR CLINICAL MICROBIOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: GLOBAL IVD MARKET SIZE FOR HEMATOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 56: GLOBAL IVD MARKET SIZE FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: GLOBAL OTHER IVD TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: GLOBAL IVD MARKET SIZE, BY APPLICATION, 2014 - 2021 (USD MILLION)
  • TABLE 59: GLOBAL DIABETIC PATIENT POPULATION IN 2015 AND 2040 (MILLION)
  • TABLE 60: GLOBAL IVD MARKET SIZE FOR DIABETES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 61: GLOBAL IVD MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 62: U.S.: CANCER INCIDENCE RATE, BY REGION (PER 100,000 INDIVIDUALS) 2008-2012
  • TABLE 63: GLOBAL IVD MARKET SIZE FOR ONCOLOGY/CANCER, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: GLOBAL IVD MARKET SIZE FOR CARDIOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 65: GLOBAL IVD MARKET SIZE FOR NEPHROLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: GLOBAL IVD MARKET SIZE FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 67: GLOBAL IVD MARKET SIZE FOR DRUG TESTING/PHARMACOGENOMICS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 68: GLOBAL IVD MARKET SIZE FOR HIV/AIDS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 69: GLOBAL IVD MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 70: GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 71: GLOBAL IVD MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 72: GLOBAL IVD MARKET SIZE FOR LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 73: GLOBAL IVD MARKET SIZE FOR POC TESTING, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 74: GLOBAL IVD MARKET SIZE FOR PATIENT SELF-TESTING, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 75: GLOBAL IVD MARKET SIZE FOR ACADEMIC INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 76: GLOBAL IVD MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 77: GLOBAL IVD MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 78: GLOBAL IVD MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 79: NORTH AMERICA: IVD MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 80: NORTH AMERICA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 81: NORTH AMERICA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 82: NORTH AMERICA: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 83: NORTH AMERICA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 84: U.S.: MACROECONOMIC INDICATORS
  • TABLE 85: U.S.: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 86: U.S.: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 87: U.S.: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 88: U.S.: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 89: CANADA: MACROECONOMIC INDICATORS
  • TABLE 90: CANADA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 91: CANADA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 92: CANADA: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 93: CANADA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 94: EUROPE: IVD MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 95: EUROPE: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 96: EUROPE: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 97: EUROPE: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 98: EUROPE: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 99: GERMANY: MACROECONOMIC INDICATORS
  • TABLE 100: GERMANY: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 101: GERMANY: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 102: GERMANY: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 103: GERMANY: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 104: FRANCE: MACROECONOMIC INDICATORS
  • TABLE 105: FRANCE: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 106: FRANCE: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 107: FRANCE: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 108: FRANCE: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 109: U.K.: MACROECONOMIC INDICATORS
  • TABLE 110: U.K.: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 111: U.K.: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 112: U.K.: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 113: U.K.: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 114: ITALY: MACROECONOMIC INDICATORS
  • TABLE 115: ITALY: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 116: ITALY: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 117: ITALY: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 118: ITALY: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 119: SPAIN: MACROECONOMIC INDICATORS
  • TABLE 120: SPAIN: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 121: SPAIN: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 122: SPAIN: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 123: SPAIN: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 124: RUSSIA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 125: RUSSIA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 126: RUSSIA: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 127: RUSSIA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 128: ROE: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 129: ROE: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 130: ROE: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 131: ROE: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 132: APAC: IVD MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 133: APAC: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 134: APAC: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 135: APAC: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 136: APAC: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 137: JAPAN: MACROECONOMIC INDICATORS
  • TABLE 138: JAPAN: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 139: JAPAN: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 140: JAPAN: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 141: JAPAN: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 142: CHINA: MACROECONOMIC INDICATORS
  • TABLE 143: CHINA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 144: CHINA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 145: CHINA: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 146: CHINA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 147: INDIA: MACROECONOMIC INDICATORS
  • TABLE 148: INDIA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 149: INDIA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 150: INDIA: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 151: INDIA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 152: ROAPAC: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 153: ROAPAC: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 154: ROAPAC: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 155: ROAPAC: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 156: LATIN AMERICA: IVD MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 157: LATIN AMERICA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 158: LATIN AMERICA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 159: LATIN AMERICA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2021 (USD MILLION)
  • TABLE 160: LATIN AMERICA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 161: BRAZIL: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 162: BRAZIL: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 163: BRAZIL: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 164: BRAZIL: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 165: MEXICO: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 166: MEXICO: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 167: MEXICO: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 168: MEXICO: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 169: ROLA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 170: ROLA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 171: ROLA: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 172: ROLA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 173: MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 174: MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 175: MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 176: MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 177: NEW PRODUCT LAUNCHES, 2013-2016
  • TABLE 178: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
  • TABLE 179: ACQUISITIONS, 2013-2016
  • TABLE 180: EXPANSIONS, 2013-2016
  • TABLE 181: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL IN VITRO DIAGNOSTICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: GLOBAL IVD MARKET SIZE, BY PRODUCTS & SERVICES, 2016 VS. 2021 (USD MILLION)
  • FIGURE 7: GLOBAL IVD MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: GLOBAL IVD MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: GLOBAL IMMUNOASSAY/IMMUNOCHEMISTRY MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 12: GLOBAL IVD MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 13: GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET
  • FIGURE 14: RISING INCIDENCE OF CHRONIC LIFESTYLE DISEASES IS DRIVING GROWTH OF THE IN VITRO DIAGNOSTICS MARKET
  • FIGURE 15: REAGENTS & KITS COMMANDED THE LARGEST SHARE IN 2015
  • FIGURE 16: THE U.S. ACCOUNTED FOR LARGEST SHARE OF THE IN VITRO DIAGNOSTICS MARKET IN 2015
  • FIGURE 17: APAC TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 18: DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 19: IVD MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN THE U.S. (MILLION INDIVIDUALS)
  • FIGURE 21: MAJOR TRENDS IN THE IVD MARKET
  • FIGURE 22: CANADA: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 23: EUROPE: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 24: INDIA: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 25: REAGENTS & KITS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 26: MOLECULAR DIAGNOSTICS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 27: ONCOLOGY, THE FASTEST-GROWING APPLICATION SEGMENT OF THE IVD MARKET
  • FIGURE 28: GLOBAL HIV POPULATION (2010-2015)
  • FIGURE 29: GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 30: GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA-PACIFIC ARE EMERGING GROWTH HOTSPOTS
  • FIGURE 31: GLOBAL IVD MARKET SHARE, BY REGION, 2015 VS. 2021
  • FIGURE 32: NORTH AMERICA: IVD MARKET SNAPSHOT
  • FIGURE 33: U.S.: CHRONIC DISEASES PREVALENCE (1995-2030)
  • FIGURE 34: EUROPE: IVD MARKET SNAPSHOT
  • FIGURE 35: APAC: IVD MARKET SNAPSHOT
  • FIGURE 36: PLAYERS MAJORLY ADOPTED THE STRATEGY OF PRODUCT LAUNCH FROM 2013 TO 2016
  • FIGURE 37: GLOBAL IN VITRO DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 38: BATTLE FOR MARKET SHARE: PRODUCT LAUNCH WAS THE KEY STRATEGY
  • FIGURE 39: GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS
  • FIGURE 40: ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 41: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 42: BIOMERIEUX SA: COMPANY SNAPSHOT
  • FIGURE 43: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 44: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 45: JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
  • FIGURE 46: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 47: SIEMENS AG: COMPANY SNAPSHOT
  • FIGURE 48: SYSMEX CORPORATION: COMPANY SNAPSHOT
  • FIGURE 49: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 50: QIAGEN N.V.: COMPANY SNAPSHOT
  • FIGURE 51: DIASORIN S.P.A.: COMPANY SNAPSHOT
Back to Top